Evolution of HIV and HCV coinfected children receiving long-term lopinavir/ritonavir-based antiretroviral therapy

被引：0
|
作者：
Larru, Beatriz [1 ]
Resino, Salvador [1 ,2 ]
Bellon, Jose M. [1 ]
Isabel de Jose Gomez, M. [3 ]
Fortuna, Claudia [4 ]
Munoz-Fernandez, M. Angeles [1 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid 28007, Spain
[2] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain
[3] Hosp Univ La Paz, Serv Inmunopediat, Madrid, Spain
[4] Hosp San Joan de Deu, Serv Inmunopediat, Barcelona, Spain
来源：
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2008年 / 26卷 / 07期
关键词：
HIV; HCV; LPV/r; HAART; children;
D O I：
10.1157/13125640
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
INTRODUCTION. There are few studies investigating the effect of HCV coinfection on HIV-related disease among children. METHODS. We studied 5 HIV/HCV coinfected children receiving an LPV/r-containing HAART regimen. Their evolution was compared with a control group of 72 HIV-infected children. RESULTS. All 5 HIV/HCV-coinfected children achieved sustained immune recovery during the study. Moreover, they showed better viral suppression than the control group. None of the 5 HIV/HCV-coinfected children experienced any adverse effects with the use of LPV/r. CONCLUSION. HIV/HCV coinfection does not reduce the benefits obtained from HAART.
引用
收藏
页码：426 / 429
页数：4
相关论文
共 50 条
  • [41] Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naive Patients with HIV-1 Infection: the REMAIN Study
    Teofilo, Eugenio
    Rocha-Pereira, Nuno
    Kuhlmann, Birger
    Antela, Antonio
    Knechten, Heribert
    Santos, Jesus
    Jesus Jimenez-Exposito, Maria
    HIV CLINICAL TRIALS, 2016, 17 (01): : 17 - 28
  • [42] Growth in HIV-infected children on long-term antiretroviral therapy
    Feucht, Ute D.
    Van Bruwaene, Lore
    Becker, Piet J.
    Kruger, Mariana
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2016, 21 (05) : 619 - 629
  • [43] Predictors of Virologic and Clinical Response to Nevirapine versus Lopinavir/Ritonavir-based Antiretroviral Therapy in Young Children With and Without Prior Nevirapine Exposure for the Prevention of Mother-to-child HIV Transmission
    Lindsey, Jane C.
    Hughes, Michael D.
    Violari, Avy
    Eshleman, Susan H.
    Abrams, Elaine J.
    Bwakura-Dangarembizi, Mutsa
    Barlow-Mosha, Linda
    Kamthunzi, Portia
    Sambo, Pauline M.
    Cotton, Mark F.
    Moultrie, Harry
    Khadse, Sandhya
    Schimana, Werner
    Bobat, Raziya
    Zimmer, Bonnie
    Petzold, Elizabeth
    Mofenson, Lynne M.
    Jean-Philippe, Patrick
    Palumbo, Paul
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (08) : 846 - 854
  • [44] Long-term virological effectiveness with darunavir/ritonavir-based salvage therapy in people living with HIV/AIDS from Sao Paulo, Brazil
    Ramos dos Santos, Ariane Melare
    Martins, Amaury Pachione
    Juliato, Denise
    Farias Peixoto de Miranda, Erique Jose
    Silva Lopez Lopes, Giselle Ibette
    de Macedo Brigido, Luis Fernando
    Vidal, Jose Ernesto
    INTERNATIONAL JOURNAL OF STD & AIDS, 2020, 31 (10) : 967 - 975
  • [45] Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression
    Pulido, Federico
    Delgado, Rafael
    Perez-Valero, Ignacio
    Gonzalez-Garcia, Juan
    Miralles, Pilar
    Arranz, Alberto
    Hernando, Asuncion
    Arribas, Jose R.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (06) : 1359 - 1361
  • [46] Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
    Valérie Martinez
    Thi Dieu Ngan TA
    Zahra Mokhtari
    Marguerite Guiguet
    Patrick Miailhes
    Marc-Antoine Valantin
    Fréderic Charlotte
    Philippe Bertheau
    Jean-Michel Molina
    Christine Katlama
    Eric Caumes
    Genome Biology, 13 (3)
  • [47] Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
    Valrie Martinez
    Thi Dieu Ngan TA
    Zahra Mokhtari
    Marguerite Guiguet
    Patrick Miailhes
    Marc-Antoine Valantin
    Frderic Charlotte
    Philippe Bertheau
    Jean-Michel Molina
    Christine Katlama
    Eric Caumes
    BMC Research Notes, 5 (1)
  • [48] Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
    Valérie Martinez
    Thi Dieu Ngan TA
    Zahra Mokhtari
    Marguerite Guiguet
    Patrick Miailhes
    Marc-Antoine Valantin
    Fréderic Charlotte
    Philippe Bertheau
    Jean-Michel Molina
    Christine Katlama
    Eric Caumes
    Genome Biology, 13 (3)
  • [49] Different kinetics of immunologic recovery using nelfinavir or lopinavir/ritonavir-based regimens in children with perinatal HIV-1 infection
    De Luca, M
    Miccinesi, G
    Chiappini, E
    Zappa, M
    Galli, L
    De Martino, M
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2005, 18 (04) : 729 - 735
  • [50] Darunavir-based Antiretroviral Therapy may Affect the Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in HCV/HIV-1 Coinfected Patients
    Sollima, Salvatore
    D'Avolio, Antonio
    Cattaneo, Dario
    Micheli, Valeria
    Milazzo, Laura
    Gervasoni, Cristina
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (02) : 285 - U148
12345